Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Pegaptanib sodium
Drug ID BADD_D01691
Description Pegaptanib is a polynucleotide aptamer. Pegatinib aids neovascular age-related macular degeneration by binding to VEGF which in order reduces angiogenesis and vessel permeability. Pegaptanib was granted FDA approval on 17 September 2004.[L17903]
Indications and Usage For the treatment of neovascular (wet) age-related macular degeneration.
Marketing Status approved; investigational
ATC Code S01LA03
DrugBank ID DB04895
KEGG ID D05386
MeSH ID C495058
PubChem ID 56603655
TTD Drug ID D0UF9W
NDC Product Code Not Available
UNII 3HP012Q0FH
Synonyms pegaptanib | Macugen | pegaptanib sodium
Chemical Information
Molecular Formula C22H44N3O10P
CAS Registry Number 222716-86-1
SMILES COCCOC(=O)NCCCCC(C(=O)NCCCCCCCOP(=O)(C)O)NC(=O)OCCOC
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaphylactic reaction10.01.07.001; 24.06.03.006--
Anaphylactoid reaction10.01.07.003; 24.06.03.007---
Angioedema10.01.05.009; 22.04.02.008; 23.04.01.001---
Arthritis15.01.01.001--
Blepharitis06.04.04.001; 23.03.04.012---
Bronchitis11.01.09.001; 22.07.01.001--
Cataract06.06.01.001--
Cataract traumatic06.11.01.002; 12.01.04.008---
Cerebrovascular accident17.08.01.007; 24.03.05.001--
Chest pain02.02.02.011; 08.01.08.002; 22.12.02.003---
Conjunctival haemorrhage06.07.01.001; 24.07.05.001---
Conjunctival oedema06.04.01.001---
Conjunctivitis06.04.01.002; 11.01.06.012--
Conjunctivitis allergic06.04.01.003; 10.01.04.002---
Corneal abrasion06.11.03.001; 12.01.04.001---
Corneal deposits06.06.03.002---
Corneal oedema06.04.02.001---
Deafness04.02.01.001---
Dermatitis contact10.01.01.003; 12.03.01.040; 23.03.04.004---
Diabetes mellitus05.06.01.001; 14.06.01.001---
Diarrhoea07.02.01.001--
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.007--
Dyspepsia07.01.02.001--
Endophthalmitis06.04.05.009; 11.01.06.003--
Exostosis15.02.04.005--
Eye discharge06.04.05.001---
Eye inflammation06.04.05.002---
Eye irritation06.04.05.003---
Eye pain06.08.03.002--
Eye swelling06.08.03.003---
The 1th Page    1 2    Next   Last    Total 2 Pages